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In the previous pai=ers, Hiroya Umemura and Takeshi Kuyama reported the results 
of experimental studies on the effects of synthetic glutathione (Tachion Yamanouchi) 
for the protection of the injurious effects of the hyperbaric oxygenation at the patients 
and the attendants This p'.lpers deals with s:Jme problems on hyperbaric harmful effects 
with the protection for them. 
From 1st, October, 1967 to 30th, November, 1967, thirty times of 2-3 absolute kg. 
per cm2G hyperbaric oxygenation therapy were performed at 20 patients, as shown on 4 
tables and 2 photographies. 
Few doctors were suffered with the aseptic otitis media, after some services of the 
hyperbaric oxygenation inside the hyperbaric chamber, and none of patients and doctors 
were suffered with caison dise&se, acute oxygen toxicosis and so on, after the hyperbaric 
service, too. But after a long period of the hyperbaric works, few attendants complained 
head-ache and vertigo. The intravenous injections of synthetic glutathione were done at. 
some attendants, and none of whom complained vertigo and head-ache. When the period 
of the hyperbaric experiences of attendants is over seven hours at two kg/cm2G increased 
ambient pressures, the authors cal attention of protective means against the injurious 
effects of hyperbaric environments like the intravenous injections of synthetic gluthatione 
should be considered, not only for patients but also for attendants. 
If any patients of shock were treated either with or without surgery, inside the hyi=er-
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baric chamber, such patients should not be left alone without doctor. 
When any patients of shock is treated inside the hyperbaric chamber, hyperbaric 
doctors should not take such patients out from the hyperbaric chamber to normal enviro-
nments, until symptomes of shock is completely healed out. Otherwise, patients might 
come back to the stage of shock or hypoxia, rather more serious than before the hyper-
baric oxgenations. The authors like to cal such phenomena “Rebound hypoxia after the 
hyperbaric oxygenation’＇. Such hypoxia cause the death of patients if the doctors do not 
bring such patients back to the hyperbaric oxygenations chamber, immediately. 
Stil the hyperbaric medicine has so many unclear problems. For instance, concerning 
to brain, even if arterial blood pressure is 10 40 mmHg at the shock patient, patient is 
very clear in the consiousness but at acute embolism or acute thrombosis of brain, con・
siousness is disturbed. On the other words, brain function at the hypotensive patients is 
activated by the hyperbaric oxygenation but the deficits of patients immediately after the 
acute embolism of the central nerve system can not be healed out inside the hyperbaric 
chamber. 
On the other papers, Umemura and Kuyama reported the intravenous injections of 
reductive synthetic glutathione were effective in the protection of the injurious effects of 
the hyperbaric oxygenation at rats, and also the authors find the reports of N.A.S.A. 
The United States concerning the following facts, that, if rats were fed during long time, 
at the hyperoxic environments, the contents of the glutathione in the red blood cels de-
rease, on the proceeding of the fifth congress of the hyperbaric medicine at Duke Uni-
versity. 
Conclusively, the authors emphasized in this papers, that medical teams and patients 
for the hyperbaric medical activities must be protected from the pathogenetic r四ctionsof 
the increased ambient pressures. For this purpose the use of antioxidants and the syn-

































表 2 試逆転開始 9月31日 試運転終了 11月20日 11例 17回
使用氏名 年令 病 名 高圧下治療行為 ｜ 麻酔
1 村0恒0 I 52合！ j汗破裂
2 西O重0 I i1 合 l 下肢A-VFistel






4 清0遥oI 39 合 ｜ 癌性腹膜炎 : Auアイソトープ増感 i意識下 （中耳炎）
5 林 0信
6 堀O芳O
55 合 ｜ 癒性腹膜炎 : Auアイソトーフ附！改 意識下
50 合 i 癌性腹膜炎 1 Auアイソトープ培感 意識下
7 大O木O夫 21 合 胃癌肝転移
8 辻 0夫 42 合 特発性脱痘
9 篠0 -0 39 合 特発性脱痘
10 山0 三O 60 合 癌性腹膜炎
11 大O 俊O 19 合 グラピッツ全身転移
表 3
症例番号同点司百｜所用人員｜白註｜転記
(1) 2 8.5 
(2) 3 6.0 
(3) 2 1. 5 
(4) 2 1. 5 
(5) 2 1. 5 
(6) 2 1. 5 
(7) 2 1. 5 
(8) 2 1. 5 
(9) 2 1. 5 
U日 2 1. 5 







































































表5 Mortalitie，、 ofmice which were expo担dby the hyperb訂icpure oxygenation during 
5 hours tr田 tedby the various prot配tivechem』calsagainst the oxygen toxicosis 




Vit-imine E 102-b 
Cytochrcme C 105-a 
C.D.P.Choline 106-b 
Contrcl (Sュline) 103-b 
Thiosulfr句 Na. 101-b 
Vitamine C 107-b 
Preadoni叫 lone 105-b 
C.D.P.Choline 104-b 
Cysteine 103-b 
Vit1mine E 106-a 

























Adenosin Triphosphate r A. T. P.), Adenosin Diphos-



























の代詩J機梢障害とTric xycai b~ hydr己teCircleのFbin-
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図1 京都大学のためω．米国合衆国シカコー製ノてキユダイン 1¥1（、 96型
図2 京都大学lζ於ける高圧治療医
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図3 t：けI：恨み平外OJ，両腕動脈硬化性えそ
図 4 1：目』圧室内
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